Item 7.01 Regulation FD Disclosure

On March 2, 2021, Adamis Pharmaceuticals Corporation (the "Company") posted a corporate presentation to its website. The corporate presentation is available under the "Events and Presentations" tab in the "Investors" section of the Company's website, located at www.adamispharma.com.

The information in this Current Report on Form 8-K, including Exhibit 99.1 attached hereto, is being furnished and shall not be deemed "filed" for the purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), or otherwise subject to the liabilities of that Section, nor shall it be deemed incorporated by reference into any filing of the Company under the Securities Act of 1933, as amended, or the Exchange Act, whether made before or after the date hereof, regardless of any general incorporation language in such filing, except as may be expressly set forth by specific reference in such filing or document. Item 7.01 of this Report and the furnishing of the attached presentation is not an admission as to the materiality of any information therein. The information contained in the presentation is summary information that is intended to be considered in the context of more complete information included in the Company's filings with the U.S. Securities and Exchange Commission and other public announcements that the Company has made and may make from time to time by press release or otherwise. Except to the extent required by applicable law, the Company undertakes no duty or obligation to update or revise the information contained in this report or in the presentation.

Item 9.01 Financial Statements and Exhibits



(d) Exhibits.



Exhibit No.      Exhibit Description

  99.1             Corporate Presentation dated March 2021
104              Cover page interactive data file (embedded within the Inline XBRL
                 document).

© Edgar Online, source Glimpses